Iatrogenic risk factors are associated with occurrence of nonmelanoma skin cancer and poor prognosis in children. A PeDRA STARC Project
|
|
- Whitney Wright
- 5 years ago
- Views:
Transcription
1 Iatrogenic risk factors are associated with occurrence of nonmelanoma skin cancer and poor prognosis in children A PeDRA STARC Project
2 Nonmelanoma skin cancer is tradi0onally associated with predisposing condi0ons
3 Iatrogenic exposures associated with NMSC in adults include immunosuppression, radia0on, and voriconazole
4 Lack of risk factor iden0fica0on and access to care may delay diagnosis of NMSC in children
5 To describe clinical characteris0cs of NMSC in children and young adults. Survival No Yes Overall Survival With Number of Subjects at Risk + Censored + Censored Years from inital skin cancer diagnosis To iden0fy risk factors associated with occurrence and outcomes of NMSC. Has the patient received voriconazole? No Yes Pa#ents with iatrogenic exposures To characterize access to dermatologic care in these pa0ents.
6 Multi-center, retrospective case controlled study of 11 major academic hospitals
7 What we ve accomplished so far PeDRA 2014 PeDRA 2015 PeDRA 2016 PeDRA /14: 4/15: Global Ini0al IRB approved brainstorming 11/15: Data collec0on form finalized 3/16: IRB approval and DTAs obtained by all sites 9/16: Study pa0ent data collected by all sites 3/17: Control data collected 9/17: Data analysis 6/15: PeDRA Seed Grant 1/16: ASA Grant awarded 10/17: Data presented
8 This cohort is from a database of 438 pa0ents with melanoma or NMSC 321 with melanoma with NMSC Controls matched by sex, age, and skin type
9 126 NMSC pa#ents 126 Control pa#ents Medical record review Data collec0on into shared Redcap form Data analysis by DFCI CTIP
10 We iden0fied 96 pa0ents with BCC, 40 with SCC, and 9 with melanoma
11 We iden0fied 845 occurrences of skin cancer # of NMSC occurrences by skin cancer type Diagnosis # overall occurrences (%) BCC 718 (85) SCC invasive 87 (10) SCC in situ 36 (4) Keratoacanthoma 8 (1) Melanoma 9 (1) Total 845
12 50.4% of pa0ents had 2 skin cancers Number of Skin Cancer Lesions (Initial and Subsequent) 50 Number of patients =>18 Number of lesions
13 One-third of pa0ents were of nonwhite race and/or skin phototype BCC SCC Non-white FPT 3
14 44% of pa0ents had a predisposing condi0on Basal cell nevus syndrome (34) Xeroderma pigmentosum (11) Immunodeficiency Dyskeratosis congenita Bloom syndrome Incon0nen0a pigmen0 Epidermolysis bullosa Morphea Nevus sebaceous Wart
15 29% had 1 iatrogenic exposure Characteris#c n (%) SCC (n=40) BCC (n=97) Therapies 14 (35) 26 (27) Immunosuppression > 6 mos 12 (30) 5 (5) Radia1on therapy 5 (13) 19 (20) Chemotherapy 3 (8) 21 (22) Voriconazole use 6 (15) 2 (2) Malignancy 7/38 (18) 26/94 (28) Stem cell transplant 6 (15) 9 (9) Chronic GVHD 5/5 (100) 1/5 (25) Organ transplant 6 (15) 2 (2)
16 Immunosuppression and voriconazole use are associated with SCC occurrence SCC pa#ents vs. controls (n=40 each) Risk factors SCC, n (%) Control, n (%) p-value* Immunosuppression 12 (30) 0 (0) Radia#on therapy 5 (13) 0 (0) Chemotherapy 3 (8) 0 (0) 0.24 Voriconazole use 6 (15) 0 (0) Malignancy 7/38 (18) 0 (0) Stem cell transplant 6 (15) 0 (0) 0.03 Organ transplant 6 (15) 0 (0) 0.03
17 Radia0on and chemotherapy are associated with BCC occurrence BCC pa#ents vs. controls (n=97 each) Risk factors BCC, n (%) Control, n (%) p-value* Immunosuppression 5 (5) 2 (2) 0.44 Radia#on therapy 19 (20) 1 (1) < Chemotherapy 21 (22) 1 (1) < Voriconazole use 2 (2) 0 (0) 0.5 Malignancy 26/94 (28) 3/95 (3) < Stem cell transplant 9 (9) 0 (0) Organ transplant 2 (2) 0 (0) 0.5
18 Of 6 deaths reported, one was related to skin cancer Life status SCC (n=40) n (%) BCC (n=97) Follow-up #me in years [median (range),n] 4 (0-20.7), n= (0-22.1), n=94 Dead 4 (10) 3 (3) Life status Alive 35 (90) 89 (97) Unknown 1 5
19 Voriconazole use was significantly associated with worse overall 5-year survival Overall Survival With Number of Subjects at Risk + Censored Survival No Yes + Censored Years from inital skin cancer diagnosis Has the patient received voriconazole? No Yes
20 Pa0ents with iatrogenic exposures have decreased access to dermatologic care All pa#ents Pa#ents with iatrogenic exposures 19% 32% Saw derm before NMSC diagnosis Did not see derm before NMSC diagnosis
21 Median 0me from onset to diagnosis was 9 months, with 80% present for > 6 months prior to diagnosis
22 Children with iatrogenic exposures are at risk for nonmelanoma skin cancer Immunosuppression Voriconazole use Squamous cell carcinoma Radia0on therapy Chemotherapy Basal cell carcinoma
23 Set up referral pagerns with oncologists Educate our pa0ents Improve our access Educate our peers/ colleagues
24 Investigators and contributors Carrie C. Coughlin, MD Lawrence F. Eichenfield, MD Pedram Gerami, MD Elena Hawryluk, MD, PhD Kristen Hook, MD Jennifer T. Huang, MD Stephen Humphrey, MD Lacey Kruse, MD Leslie Lawley, MD Hasan Al-Sayegh, MBChB, MPH Wendy London, PhD Ashfaq Marghoob, MD Thuy Phung, MD, PhD Elena Pope, MD Birgitta Schmidt, MD Eman Bahrani, MD Diana Bartenstein MD Meera Brahmbhatt, MD Lily Chen, MD Kaitlyn Kollman, MD Ellen Haddock MD Danny Mansour MD Julie Nguyen, MD Tom Raisanen MD Sarah Robinson, MD Tova Rogers, MD Gary Tran, MD Kate Travis, BA Zachary Wolner, MD
Overview 2/11/18. Skin cancer surveillance after cancer therapy: When to worry. Skin cancer risk factors and types. Time to onset
Skin cancer surveillance after cancer therapy: When to worry Carrie C. Coughlin, MD Assistant Professor, Dermatology Washington University School of Medicine F072 - The Big C's: Children, Cancer, and Cutaneous
More informationLarge majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.
Basics of Skin Cancer Detection and Treatment of Non- Melanoma Skin Cancers Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest
More informationSKIN CANCER AFTER HSCT
SKIN CANCER AFTER HSCT David Rice, PhD, MSN, RN, NP, NEA-BC Director, Education, Evidence-based Practice and Research City of Hope National Medical Center HOW THE EXPERTS TREAT HEMATOLOGIC MALIGNANCIES
More informationFall 2015 IN THIS ISSUE
An to update and inform PeDRA spedra s collaborative research network Ane-newsletter e-newsletter to update and inform collaborative research network Fall 2015 IN THIS ISSUE»» Updates from the PeDRA Research
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More informationKnow who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated
Lindy P. Fox, MD Assistant Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant
More informationKnow who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated
Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant
More informationIatrogenic Immunosuppression and Cutaneous Malignancy
Iatrogenic Immunosuppression and Cutaneous Malignancy Jerry D. Brewer, MD, MS, FAAD brewer.jerry@mayo.edu Professor of Dermatology Chair Division of Dermatologic Surgery Department of Dermatology Mayo
More informationClinical characteristics
Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic
More informationDermatology Foundation
Dermatology Foundation Dermatologic Surgery & Laser Center Siegrid S. Yu, MD Associate Professor Director, Procedural Dermatology Fellowship The Dermatology Foundation has supported and furthered my career.
More informationIdentifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018
Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma
More informationA Retrospective Study on the Risk of Non-Melanoma Skin Cancer in PUVA and Narrowband UVB Treated Patients
Volume 1, Issue 3 Research Article A Retrospective Study on the Risk of Non-Melanoma Skin Cancer in PUVA and Narrowband UVB Treated Patients Darukarnphut P, Rattanakaemakorn P *, Rajatanavin N Division
More informationSkin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012
Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Case Presentation 57 yo man with 3 month hx of a nonhealing < 1 cm right
More informationAttending Physician Statement- Cancer or Carcinoma in-situ
Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Cancer or Carcinoma in-situ.
More informationAccess to insurance and stage of cervical cancer in Massachusetts
Access to insurance and stage of cervical cancer in Massachusetts Sarah Feldman MD, MPH Brigham and Women s Hospital Department of Gynecologic Oncology Boston, MA USA Co-Authors: Michelle Davis MD, Colleen
More informationRegeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018
A D E E P E R L O O K When detected early, most cases of local cutaneous squamous cell carcinoma are easily treated and usually cured. But when they become more advanced, this second most common form of
More informationCatastrophic cutaneous carcinomatosis in the non-organ transplant patient
Catastrophic cutaneous carcinomatosis in the non-organ transplant patient RyanB.Turner,MD,ImranAmir,MD,JaneY.Yoo,MD,MPP,AaronE.Fuchs,MD,DavidA.Kriegel,MD, and Ellen S. Marmur, MD New York, New York Background:
More informationSkin Cancer of the Nose: Common and Uncommon
Skin Cancer of the Nose: Common and Uncommon Mark Russell, M.D. Associate Professor of Dermatology, Otolaryngology, and Pathology University of Virginia Objectives Review clinical presentations of select
More informationPeriocular Malignancies
Periocular Malignancies Andrew Gurwood, O.D., F.A.A.O., Dipl. Marc Myers, O.D., F.A.A.O. Drs. Myers and Gurwood have no financial interests to disclose. Course Description Discussion of the most common
More informationSKIN CANCER SCREENING AT UPMC. Laura K. Ferris, MD, PhD Associate Professor of Dermatology
SKIN CANCER SCREENING AT UPMC Laura K. Ferris, MD, PhD Associate Professor of Dermatology UPMC Largest health care system in Western PA 21+ hospitals with >5,100 licensed beds More than 500 outpatient
More informationSupplementary Online Content
Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November
More informationSun exposure and indoor tanning and skin cancer
Reviews and Meta-analyses analyses of Sun exposure and indoor tanning and skin cancer Sara Gandini, PhD Division of Epidemiology and Biostatistics European Institute of Oncology - Milan, Italy Phenotypical
More informationJuly 2012 SKIN SURGERY SERVICE BRIEFING NOTES
SKIN SURGERY SERVICE BRIEFING NOTES Introduction The WBoP PHO has an agreement with the BoP District Health Board to deliver the Skin Surgery Service. The current period will expire on 30 June 2012 and
More informationSkin Tumors in Children
AAD San Diego S021 2018 Skin Tumors in Children Jane M. Grant-Kels, MD,FAAD grant@uchc.edu Founding Chair Emeritus, Derm Dept, UCONN Vice Chair Dept of Dermatology Professor of Dermatology, Pathology and
More informationChildhood Cancer Survivor Study Analysis Concept Proposal
Title: Multiple Subsequent Neoplasms Working Group and Investigators: Childhood Cancer Survivor Study Analysis Concept Proposal This proposed publication will be within the Second Malignancy Working Group
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationMalignant non-melanocytic lesions
Malignant non-melanocytic lesions Course C023: Fundamentals of Dermoscopy March 4, 2019, 11:20 AM - 11:50 PM Room: 146B Jason B. Lee, MD Professor & Vice Chair Director of Dermatopathology & Pigmented
More informationEMA Pediatric Web Synopsis Protocol A November 2011 Final PFIZER INC.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationNa#onal Neutropenia Network Family Conference July 12, 2014
Na#onal Neutropenia Network Family Conference July 12, 2014 Jim Connelly, MD Assistant Professor of Pediatrics and Communicable Diseases Blood and Marrow Transplant Program University of Michigan Transplant
More informationResearch Collaborations: Lessons from PeDRA and the SPD
Research Collaborations: Lessons from PeDRA and the SPD Amy Paller, MD Professor and Chair, Dermatology Professor, Pediatrics Northwestern Univ. Feinberg School of Medicine Chicago, IL No conflicts of
More informationRetrospective and Prospective Evaluation of Pediatric Cutaneous Mastocytosis
Retrospective and Prospective Evaluation of Pediatric Cutaneous Mastocytosis Emily Gurnee, MD(1), Thuy Phung, MD PhD(2), Emily Guo(2), Karen Resnick(2), Emma Weiss (2), Aaron Fong(2), Megha Tollefson,
More informationFast Facts: Skin Cancer
Fast Facts Fast Facts: Skin Cancer Second edition Karen L Agnew MBChB FRACP Consultant Dermatologist Auckland City and Starship Children s Hospitals Auckland, New Zealand Christopher B Bunker MA MD FRCP
More informationI have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee
I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something
More informationAccepted Manuscript. Reply to: Risk of skin cancer in HIV-infected patients: a Danish nationwide cohort study
Accepted Manuscript Reply to: Risk of skin cancer in HIV-infected patients: a Danish nationwide cohort study Matthew D. Mansh, MD, Dustin H. Marks, BS PII: S0190-9622(18)32503-9 DOI: 10.1016/j.jaad.2018.07.067
More information23/04/2015. Recent advances in Melanoma and Non Melanoma Skin Cancer
Recent advances in and Non Skin Cancer Rodney Sinclair Professor of Dermatology University of Melbourne & Epworth Hospital 86.5% increase 120% increase 37.5% increase 1 To ascertain incidence of NMSC De
More informationBasal cell carcinoma 5/28/2011
Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers
More informationTumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
ORIGINAL ARTICLE See related commentary on pg 1129 Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma Mary-Margaret Chren 1,2, Eleni Linos 1, Jeanette
More informationSkin Cancer. All You Need to Keep up to Speed. by Karen L Agnew, Barbara A Gilchrest and Christopher B Bunker. Epidemiology 9.
Skin Cancer All You Need to Keep up to Speed by Karen L Agnew, Barbara A Gilchrest and Christopher B Bunker Epidemiology 9 Pathogenesis 17 Clinical features and diagnosis 26 Management 64 Prognosis 86
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationAccuracy of Clinical Skin Tumour Diagnosis in a Dermatological Setting.
Accuracy of Clinical Skin Tumour Diagnosis in a Dermatological Setting. Ahnlide, Ingela; Bjellerup, Mats Published in: Acta Dermato-Venereologica DOI: 10.2340/00015555-1560 2013 Link to publication Citation
More informationNew and Emerging Therapies: Non-Melanoma Skin Cancers. David J. Goldberg, MD, JD Skin Laser and Surgery Specialists of NY/NJ
New and Emerging Therapies: Non-Melanoma Skin Cancers David J. Goldberg, MD, JD Skin Laser and Surgery Specialists of NY/NJ Disclosure Research Grant form Sensus Superficial Radiation Therapy (SRT) Modern
More informationOncologic Dermatology and Surgery. Dra. Elena de las Heras
Oncologic Dermatology and Surgery Dra. Elena de las Heras Review and Updates: Clinical oncology: Lymphomas PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study Launched in 2015
More informationACGME Clinical Fellowship Program: Micrographic Surgery and Dermatologic Oncology Fellowship. Program Demographics
ACGME Clinical Fellowship Program: Micrographic Surgery and Dermatologic Oncology Fellowship Program Demographics 1. Name of Host Institution: University of California San Francisco 2. Program: Dermatology
More informationCommon Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley
Common Benign Lesions and Skin Cancers 22nd May 2015 Dr Mark Foley Thank you for downloading this file. This intended to supplement the presentation given at the NZ Wound Care Conference, it is not intended
More informationSEVERITY PROFILE OF SQUAMOUS CELL CARCINOMA CASES IN A TERTIARY REFERRAL CENTER
ORIGINAL PAPERS SEVERITY PROFILE OF SQUAMOUS CELL CARCINOMA CASES IN A TERTIARY REFERRAL CENTER MIRELA NICHITA*, LILIANA GABRIELA POPA*,**, ANA MARIA FORSEA*,** ALEXANDRA NICOLESCU*, ADELINA VASILESCU*,
More informationTrends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups,
Research Original Investigation Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012 Maryam M. Asgari, MD, MPH; Howard H. Moffet, MPH; G. Thomas Ray, MBA; Charles
More informationSkin cancer by the numbers
AMERICAN ACADEMY OF DERMATOLOGY DISEASE BRIEFS Skin cancer by the numbers Melanoma and nonmelanoma (basal and squamous cell carcinoma) skin cancers are among 24 skin diseases or disease categories examined
More informationDisclosures. I have no conflicts of interest to disclose
Disclosures I have no conflicts of interest to disclose Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco 2
More informationHistory A 89 year old gentleman presenting with a scalp/forehead nodule. Patient had squamous cell carcinoma 18 m at same site, excised. Outside diagn
Case III History A 89 year old gentleman presenting with a scalp/forehead nodule. Patient had squamous cell carcinoma 18 m at same site, excised. Outside diagnoses: Squamous cell carcinoma. R/O: SCC, Melanoma,
More informationS quamous cell carcinoma (SCC) is an invasive epithelial
1161 CLINICAL SCIENCE Squamous cell carcinoma of the eyelids M J Donaldson, T J Sullivan, K J Whitehead, R M Williamson... See end of article for authors affiliations... Correspondence to: Timothy J Sullivan,
More informationTretinoin skin cancer
Tretinoin skin cancer The Borg System is 100 % Tretinoin skin cancer Topical tretinoin has been used extensively to treat photoaged skin. Retinoids administered orally in high doses appear to be effective
More informationDermoscopy: Recognizing Top Five Common In- Office Diagnoses
Dermoscopy: Recognizing Top Five Common In- Office Diagnoses Vu A. Ngo, DO Department of Family Medicine and Dermatology Choctaw Nation Health Services Authority Learning Objectives Introduction to dermoscopy
More information1 Cancer Council Queensland, Brisbane, Queensland, Australia.
Title: Diagnosis of an additional in situ does not influence survival for patients with a single invasive : A registry-based follow-up study Authors: Danny R Youlden1, Kiarash Khosrotehrani2, Adele C Green3,4,
More informationJAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351
JAM ACAD DERMATOL Research Letters 351 Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes To the Editor:
More informationSkin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1
Skin Cancer AMERICAN OSTEOPATHIC COLLEGE OF OCCUPATIONAL & PREVENTIVE MEDICINE OMED 2012 October 8, 2012 E. Robert Wanat II, D.O., M.P.H. Learning Objectives: Identify the 3 Basic Types of Skin Cancer
More informationOriginal Article. Eyelid Masses: A 10-year Survey from a Tertiary Eye Hospital in Tehran
Original Article Eyelid Masses: A 10-year Survey from a Tertiary Eye Hospital in Tehran Abbas Bagheri, Mehdi Tavakoli, Azadeh Kanaani, Reza Beheshti Zavareh 1, Hamed Esfandiari, Maryam Aletaha, Hossein
More informationSKIN CANCERS AFTER SOLID ORGAN TRANSPLANTATION: Clinicopathological features. J. Kanitakis. Dept. of Dermatology Ed. Herriot Hospital Lyon, France
SKIN CANCERS AFTER SOLID ORGAN TRANSPLANTATION: Clinicopathological features J. Kanitakis Dept. of Dermatology Ed. Herriot Hospital Lyon, France CUTANEOUS COMPLICATIONS AFTER SOLID ORGAN TRANSPLANTATION
More informationDisclosures. Melanoma and Non melanoma Skin Cancer: What You Need to Know. I have no conflicts of interest to disclose
Disclosures Melanoma and Non melanoma Skin Cancer: What You Need to Know I have no conflicts of interest to disclose Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department
More informationSkin cancer risk education in pediatric solid organ transplant patients: An evaluation of knowledge, behavior, and perceptions over time
Skin cancer risk education in pediatric solid organ transplant patients: An evaluation of knowledge, behavior, and perceptions over time Carrie C. Coughlin, Washington University Maria Perez, Washington
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
More informationWhat are the functions of the integumentary system? What are some disorders of the integumentary system?
Essential Questions: What are the functions of the integumentary system? What are some disorders of the integumentary system? How are integumentary system disorders treated? How do you relate the integumentary
More informationDevelopment and ini.al valida.on of a prognos.c nomogram for ambulatory pa.ents with advanced cancer
Session: What Does the Future Hold? Prognos7ca7on in Advanced Cancer and Clinical Decision Making Development and ini.al valida.on of a prognos.c nomogram for ambulatory pa.ents with advanced cancer Paiva
More informationPattern of skin malignancies in Manipur, India: A 5-year histopathological review
Original Article Pattern of skin malignancies in Manipur, India: A 5-year histopathological review Rajesh Singh Laishram, Alpana Banerjee, Pukhrambam Punyabati, L. Durlav Chandra Sharma Department of Pathology,
More informationCutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.
Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma
More informationSyddansk Universitet. The Danish Nonmelanoma Skin Cancer Dermatology Database
Syddansk Universitet The Danish Nonmelanoma Skin Cancer Dermatology Database Lamberg, Anna Lei; Sølvsten, Henrik; Lei, Ulrikke; Vinding, Gabrielle Randskov; Stender, Ida Marie; Jemec, Gregor Borut Ernst;
More informationSTUDY. organ transplantation are at increased risk for nonmelanoma
STUDY Incidence and Clinical redictors of a Subsequent Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients With a First Nonmelanoma Skin Cancer A Multicenter Cohort Study Gianpaolo Tessari, MD;
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationThe Plastic Surgery See and Treat Skin Cancer Clinic (SATSKIN)
The Plastic Surgery See and Treat Skin Cancer Clinic (SATSKIN) Miss Michelle Gibson BMedSc MRCS MSc Specialty Doctor in Plastic Surgery South Eastern Health and Social Care Trust Based at the Ulster hospital,
More informationSkin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden
Skin Cancer Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts 13.10.16 Skin Cancer Melanoma mole cancer - is a true cancer which can metastasize and kill Non Melanoma skin cancer
More information6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms
6 Correlating Histology and Molecular Findings in Melanocytic Neoplasms Pedram Gerami MD, Associate Professor of Dermatology and Pediatrics at Northwestern University Disclosures: I have been a consultant
More informationDataDerm Quality Measures
01 MIPS 224 NQF 0562 DataDerm Quality s Melanoma: Overutilization of Imaging Studies 02 a & b MIPS 138 Melanoma: Coordination of Care 03 MIPS 137 NQF 0650 Melanoma: Continuity of Care Recall System Percentage
More informationHealthy Skin Education in Alabama s Schools. Alabama Comprehensive Cancer Control Program
Healthy Skin Education in Alabama s Schools Alabama Comprehensive Cancer Control Program Skin cancer is the most common form of cancer in the US. Skin cancer is the uncontrolled growth of abnormal skin
More informationTopic Selection Programme. Briefing Note. Diagnosis and Management of Non-melanoma skin cancer.
Topic Selection Programme Briefing Note Briefing note title: (NMSC) Diagnosis and Management of Non-melanoma skin cancer. Potential output: Clinical Guideline Consideration panel: [Delete as appropriate:
More informationRegression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!
Regression Margaret Oliviero MSN, ARNP Harold S. Rabinovitz MD Histologically regression is characterized: melanosis fibrosis combination of both Distribution: partial or focal! Dermatoscopic terminology
More informationQuality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study
Quality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study David Hui, Neha Didwaniya, Marieberta Vidal, Seong Hoon Shin, Gary Chisholm, Joyce Roquemore, Eduardo
More informationScreening for malignant melanoma: a cost-effectiveness analysis Freedberg K A, Geller A C, Miller D R, Lew R A, Koh H K
Screening for malignant melanoma: a cost-effectiveness analysis Freedberg K A, Geller A C, Miller D R, Lew R A, Koh H K Record Status This is a critical abstract of an economic evaluation that meets the
More informationYes. Breaking Bad II: Dermoscopy of Pink-ish Things. Does it Fit? Yes 6/17/2018. Yes. Joslyn Kirby, MD, MS, MEd
Breaking Bad II: Dermoscopy of Pink-ish Things Joslyn Kirby, MD, MS, MEd Yes Observe Yes Step 2. Fit a Benign Nevus Pattern? Does it Fit? Step 1: Melanocytic? pigment network, globules, homogeneous? No
More information1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.
Skin Cancer follow up guidelines If NEW serious diagnosis given: 1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter. 2. Free prescription information details. 3.
More informationA Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons?
A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? Michael Hogarth, MD, FACP CMIO, Athena Breast Health Network Professor,
More informationSUN, SAVVY AND SKIN : A REVIEW OF SKIN CANCER IN SOUTH AFRICA AND BEYOND
SUN, SAVVY AND SKIN : A REVIEW OF SKIN CANCER IN SOUTH AFRICA AND BEYOND Dr Lester M. Davids Redox Laboratory, Dept of Human Biology University of Cape Town Crafting a Road Map for Research on Sun Exposure
More informationInflammatory Breast Cancer (IBC) Epidemiology and Prognostic factors
Inflammatory Breast Cancer (IBC) Epidemiology and Prognostic factors Y.Bensouda, I.Ouziane, H.Errihani National Institute of Oncology (NIO) Rabat-Morocco Inflammatory breast cancer 1. Agressive form of
More informationTalking to Your Clients About Skin Cancer. Objectives 9/9/2017. Amanda Friedrichs, MD, FAAD AMTA National Conference September 14, 2017
Talking to Your Clients About Skin Cancer Amanda Friedrichs, MD, FAAD AMTA National Conference September 14, 2017 Objectives Provide general information about skin cancer and how skin cancers commonly
More informationCancer Epidemiology in Fanconi Anemia
Cancer Epidemiology in Fanconi Anemia FA Camp 2010 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Resources Source N Retrospective: Literature
More informationRadiation (ebt/hdr) for Non-Melanoma Skin Cancers (NMSCC) in the Dermatologist s Office: A Radiation Oncologist s (Generally Positive) Perspective
Radiation (ebt/hdr) for Non-Melanoma Skin Cancers (NMSCC) in the Dermatologist s Office: A Radiation Oncologist s (Generally Positive) Perspective Mohammad K Khan MD Ph.D FACRO Associate Professor Director,
More informationIT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY
IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,
More informationSTUDY. Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin
Subsequent Cancers After In Situ and Invasive Squamous Cell Carcinoma of the Skin Kari Hemminki, MD, PhD; Chuanhui Dong, MD, PhD STUDY Objectives: To compare cancer risks after in situ and invasive squamous
More informationJohn Strasswimmer MD, PhD
John Strasswimmer MD, PhD MIAMI CANCER 2018: NOVEL THERAPIES FOR BCC AND SCC OF SKIN AND MERKEL CELL CARCINOMA. MEDICAL DIRECTOR, MELANOMA & CUTANEOUS ONCOLOGY LYNN CANCER INSTITUTE - BOCA RATON REGIONAL
More informationDisclosure. Objectives. PAFP CME Conference Lou Mancano MD, FAAFP Reading Health System November 18, 2016
PAFP CME Conference Lou Mancano MD, FAAFP Reading Health System November 18, 2016 1 Disclosure The speaker has no conflict of interest, financial agreement, or working affiliation with any group or organization.
More informationINVESTIGATION. Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center *
INVESTIGATION s Epidemiological profile of nonmelanoma skin cancer in renal transplant recipients: experience of a referral center * 745 Flávia Regina Ferreira 1 Marilia Marufuji Ogawa 2 Luiz Fernando
More informationSince demonstrated in 1974 to be highly effective for
Incidence and Risk Factors Associated with a Second Squamous Cell Carcinoma or Basal Cell Carcinoma in Psoralen + Ultraviolet A Light-treated Psoriasis Patients Kenneth A. Katz, Isabelle Marcil,* and Robert
More informationSkin cancer excision performance in Scottish primary and secondary care:
Research Wei Yann Haw, Pariyawan Rakvit, Susannah J Fraser, Andrew G Affleck and S Alexander Holme Skin cancer excision performance in Scottish primary and secondary care: a retrospective analysis Abstract
More informationPanel consensus was not to include suggested revision.
DFSP-2 Footnote f should be revised to more accurately reflect current practice and the supporting literature and should read, 5,000-6,600 cgy for close-to-positive or positive margins (200 cgy fractions
More informationUTILIZATION OF ONCOTYPE DX TO GUIDE TREATMENT FOR EARLY STAGE BREAST CANCER. Rosemary Cress, DrPH
UTILIZATION OF ONCOTYPE DX TO GUIDE TREATMENT FOR EARLY STAGE BREAST CANCER Rosemary Cress, DrPH June 16, 2015 Introduction Therapy for women with early stage breast cancer typically includes, surgery
More informationPost Transplant Immunosuppression: Consideration for Primary Care. Sameh Abul-Ezz, M.D., Dr.P.H.
Post Transplant Immunosuppression: Consideration for Primary Care Sameh Abul-Ezz, M.D., Dr.P.H. Objectives Discuss the commonly used immunosuppressive medications and what you need to know to care for
More informationThe Old, The New and the Reemerging-HIV Dermatology. Toby Maurer, MD
The Old, The New and the Reemerging-HIV Dermatology Toby Maurer, MD 1 Psoriasis Widespread psoriasis, especially if it was once stable, predicts falling CD4 count?resistance to ART??Non-adherence? Tx:
More informationGood Samaritan Oncology Services. Vincennes, Indiana
Good Samaritan Oncology Services Vincennes, Indiana } Classified as a Community Cancer Center by CoC >100 and < 500 newly diagnosed cases each year Provide a full range of diagnostic and treatment services.
More informationSKIN CANCER. Most common cancer diagnosis 40% of all cancers
SKIN CANCER Most common cancer diagnosis 40% of all cancers OBJECTIVES Review common and uncommon cancers of the skin. Special emphasis on melanoma and dysplastic nevus Review pathology/tnm/staging, which
More informationOver the past decade, the Internet has emerged
Internet Use and Anxiety in People with Melanoma and Nonmelanoma Skin Cancer MATHEW W. LUDGATE, MBCHB, MICHAEL S. SABEL, MD, y DOUGLAS R. FULLEN, MD, z MARCUS L. FROHM, MD, JULIA S. LEE, MS, y MICK P.
More informationBlood and Marrow Transplantation for Haemoglobinopathies. Dr Josu de la Fuente St. Mary s Hospital London
Blood and Marrow Transplantation for Haemoglobinopathies Dr Josu de la Fuente St. Mary s Hospital London Aim: Stem Cell Transplanta.on 1. Eradicate of disease = achieve myeloabla8on 2. Avoid rejec8on
More information